Duality Advisers, LP Zai Lab LTD Transaction History

Duality Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$54.9 - $105.21 $556,082 - $1.07 Million	-10,129 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$105.0 - $178.37 $819,420 - $1.39 Million	7,804 Added 335.66%	10,129 $1.07 Million
Q2 2021 Aug 09, 2021	SELL	$125.11 - $180.0 $480,422 - $691,200	-3,840 Reduced 62.29%	2,325 $412,000
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $778,454 - $1.18 Million	6,165 New	6,165 $823,000

123

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.55B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.